The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


PHST OJSC PHARMSTANDARD GDR (4 GDRS EACH REPR 1 ORD) (REG S)

OJSC PHARM S  Currency  USD  Standard GDRs


Income Statement  ($ m) 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10 31-Dec-09
Continuing Operations
Revenue  1700.21 1663.52 1332.93 974.43 795.02
Operating Profit/(Loss)  480.40 407.49 345.29 291.37 285.68
Net Interest  3.85 1.11 0.94 0.59 2.37
Profit Before Tax  482.40 411.47 351.18 300.15 285.25
Profit After Tax  362.51 326.39 276.02 235.14 226.09
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  362.51 326.39 276.02 235.14 226.09
Attributable to:
Minority Interests  -3.49 -5.67 -1.63 -0.47 -0.53
Equity Holders of Parent Company  359.03 320.72 274.39 234.68 225.57
 
Continuing EPS
Earnings per Share - Basic  1036.77¢ 906.36¢ 756.47¢ 620.96¢ 596.84¢
Earnings per Share - Diluted  1036.77¢ 906.36¢ 756.47¢ 620.96¢ 596.84¢
Earnings per Share - Adjusted  1036.77¢ 906.36¢ 756.47¢ 620.96¢ 596.84¢
Continuing and Discontinued EPS
Earnings per Share - Basic  1036.77¢ 906.36¢ 756.47¢ 620.96¢ 596.84¢
Earnings per Share - Diluted  1036.77¢ 906.36¢ 756.47¢ 620.96¢ 596.84¢
Earnings per Share - Adjusted  1036.77¢ 906.36¢ 756.47¢ 620.96¢ 596.84¢
 
Dividend per Share  0.00¢ 0.00¢ 0.00¢ 0.00¢ 0.00¢

Balance Sheet  ($ m) 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10 31-Dec-09
Assets
Non-Current Assets
Property, Plant & Equipment  209.50 199.97 129.40 110.19 115.94
Intangible Assets  97.39 263.46 209.93 219.47 203.32
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  61.31 14.31 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  46.05 49.47 44.41 32.67 5.68
  414.25 527.21 383.73 362.32 324.93
Current Assets
Inventories  227.68 276.45 223.29 245.07 91.02
Trade & Other Receivables  750.56 512.45 480.09 429.20 319.54
Cash at Bank & in Hand  467.26 277.22 168.22 136.43 92.32
Current Asset Investments  44.20 146.42 107.69 120.86 37.39
Other Current Assets  0.00 0.18 0.00 0.00 0.00
  1489.70 1212.71 979.29 931.55 540.28
 
Total Assets  1903.95 1739.92 1363.02 1293.88 865.21
 
Liabilities
Current Liabilities
Borrowings  -221.37 -7.92 -22.92 -12.99 -12.91
Other Current Liabilities  -788.16 -418.79 -374.94 -377.26 -160.96
  -1009.53 -426.71 -397.86 -390.25 -173.88
 
Net Current Assets  480.17 786.01 581.43 541.30 366.41
 
Non-Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 -12.92
Provisions  -5.66 -25.64 -18.18 -21.08 -26.63
Other Non-Current Liabilities  -4.59 -2.91 -0.29 -0.37 -1.95
  -10.24 -28.55 -18.47 -21.45 -41.49
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -1019.77 -455.26 -416.33 -411.71 -215.37
 
Net Assets  884.18 1284.66 946.69 882.17 649.84
 
Capital & Reserves
Share Capital  1.15 1.24 1.18 1.24 1.25
Share Premium Account  0.00 0.00 0.00 0.00 0.00
Other Reserves  0.71 -0.17 0.72 -0.01 0.00
Retained Earnings  838.35 1229.50 928.69 866.88 634.94
Shareholders Funds  840.21 1230.58 930.59 868.11 636.19
 
Minority Interests/Other Equity  43.97 54.09 16.09 14.06 13.66
Total Equity  884.18 1284.66 946.69 882.17 649.84

Ratios - based on IFRS 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10 31-Dec-09
Continuing Operations
PE Ratio - Adjusted  0.01 0.02 0.02 0.05 0.03
PEG - Adjusted  0.00 0.00 0.00 0.01 0.00
Earnings per Share Growth - Adjusted  14.39% 19.81% 21.82% 4.04% 96.55%
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  4.91¢ 4.70¢ 3674.83¢ 2578.34¢ 1997.88¢
Pre-Tax Profit per Share  1.39¢ 1.16¢ 968.17¢ 794.20¢ 716.83¢
Operating Margin  28.26% 24.50% 25.90% 29.89% 35.88%
Return on Capital Employed  47.96% 39.12% 45.27% 43.16% 57.64%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  2043.18¢ 2794.88¢ 1362.06¢ 1716.31¢ 1145.37¢
Net Gearing  -29.27% -21.88% -15.61% -14.22% -10.45%

Data is provided by Morningstar


OJSC PHARM S share - fundamentals

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds